Effect of melatonin on sleep quality in patients with chronic obstructive pulmonary disease

Effect of melatonin on sleep quality in patients with chronic obstructive pulmonary disease: a before-after clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N533

Enrollment

Registered

2024-10-09

Start date

2025-04-04

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention group: Treatment and routine care of patients with chronic obstructive pulmonary disease plus Melatonin tablets 3 mg one hour before bed for 2 weeks.

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age 18 to 80 years Chronic obstructive pulmonary disease

Exclusion criteria

Exclusion criteria: Presence of obstructive sleep apnea Taking sedatives Oxygen therapy

Design outcomes

Primary

Measure	Time frame
Sleep quality. Timepoint: Before the intervention and two weeks after the intervention. Method of measurement: Using the Pittsburgh Sleep Quality Index (PSQI).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Gohari

Hamedan University of Medical Sciences

fatemeh.goharii78@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026